SCHEMBL25539100

SCHEMBL25539100

CC1(C)c2cccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5-c5ccc(-c6ccccc6)cc5)n4)c4ccccc34)c2-c2ccc3ccccc3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
MAPT P10636 4/20 0.34
HPGD P15428 4/20 0.34
KDM4E B2RXH2 3/20 0.34
ACACA Q13085 1/20 0.33
ENPP3 O14638 1/20 0.33
ENPP1 P22413 1/20 0.33
PSD A5PKW4 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
PIM1 P11309 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
RXRA P19793 1/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
NTSR1 P30989 1/20 0.31
PTGES O14684 1/20 0.31
CA12 O43570 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540414 1.00 ALDH1A1 (0.34) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25539080 0.98 MAPT (0.35) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25540241 0.98 MAPT (0.35) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25539111 0.97 KDM4E (0.33) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25539109 0.96 KDM4E (0.33) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25539095 0.96 CYP1A1 (0.34) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25540410 0.96 CYP1A1 (0.34) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25539077 0.96 CYP1A1 (0.34) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25540238 0.96 CYP1A1 (0.34) ALDH1A1MAPTHPGDKDM4EACACA
SCHEMBL25539943 0.95 ENPP3 (0.36) ALDH1A1MAPTHPGDKDM4EACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALDH1A1 254/4885MAPT 1595/4885HPGD 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.